FDx Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-55,949
Closed -$727K 1007
2018
Q1
$727K Sell
55,949
-171
-0.3% -$2.19K 0.02% 618
2017
Q4
$773K Buy
56,120
+899
+2% +$12.2K 0.02% 634
2017
Q3
$725K Sell
55,221
-1,935
-3% -$24.9K 0.02% 646
2017
Q2
$736K Sell
57,156
-7,685
-12% -$102K 0.02% 623
2017
Q1
$836K Buy
64,841
+1,698
+3% +$21.7K 0.03% 584
2016
Q4
$777K Buy
63,143
+28,421
+82% +$368K 0.02% 609
2016
Q3
$513K Sell
34,722
-2,104
-6% -$31.8K 0.02% 610
2016
Q2
$560K Sell
36,826
-5,868
-14% -$83K 0.03% 561
2016
Q1
$554K Sell
42,694
-45
-0.1% -$513 0.03% 545
2015
Q4
$492K Buy
42,739
+6,822
+19% +$77.9K 0.02% 563
2015
Q3
$397K Buy
35,917
+15,809
+79% +$196K 0.03% 527
2015
Q2
$264K Sell
20,108
-692
-3% -$9.65K 0.01% 796
2015
Q1
$306K Buy
20,800
+3,821
+23% +$56.8K 0.01% 1205
2014
Q4
$234K Sell
16,979
-2,872
-14% -$38.5K 0.01% 807
2014
Q3
$243K Buy
19,851
+1,954
+11% +$26K 0.02% 857
2014
Q2
$237K Sell
17,897
-486
-3% -$6.45K 0.02% 882
2014
Q1
$235K Buy
+18,383
New +$236K 0.02% 682

Other funds holding MPT

FDx Advisors's MPT Position: Q2 2018 in Review

FDx Advisors sold out of Medical Properties Trust (MPT) in Q2 2018, closing a stake of 55,949 shares — an estimated $727K sold.

FDx Advisors first reported a position in MPT in Q1 2014 and held it in 17 quarters. The position peaked at $836K in Q1 2017. 366 funds tracked by Wall St. Rank hold MPT as of Q2 2018.

  • FDx Advisors reported no remaining Medical Properties Trust position as of Q2 2018 after selling out during the quarter.
  • FDx Advisors sold 55,949 Medical Properties Trust shares in Q2 2018, an estimated $727K.
  • FDx Advisors first reported a position in Medical Properties Trust in Q1 2014 and held it in 17 quarters.
  • FDx Advisors's Medical Properties Trust position peaked at $836K in Q1 2017.
  • 366 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2018.

Based on FDx Advisors's 13F filing for Q2 2018, filed 8 Aug 2018.